# Biommune Technologies Inc. — Form D

Biommune Technologies Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-30. The offering totals $600K, of which $600K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-11-30
- Form: D
- Accession: 0001176256-15-000365
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $600K
- Amount sold: $600K
- Investors: 3
- Date of first sale: 2015-11-18
- Revenue range: No Revenues
- SEC file number: 021-252110

## Issuer

- Name: Biommune Technologies Inc.
- CIK: 0001659574
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2011
- Address: Suite 1780 - 400 Burrard St., VANCOUVER, A1, V6C 3A6
- Phone: 778-389-2936

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| JENS BIERTUMPEL | Director | Charlottesville, VA |
| Michael Hutchison | Director | Squamish, A1 |
| Rob Hutchison | Director | SURREY, A1 |
| Karoly Nikolich | Director | Cambridge, MA |
| TERRY PEARSON | Director | SOUTH SURREY, A1 |
| Judi Dalling | Executive Officer | Vancouver, A1 |
| Reinhard Gabathuler | Executive Officer | Verdun, A8 |
| PATRICK W GRAY | Executive Officer | SEATTLE, WA |

## More

- [CIK 1659574 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1659574&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001176256-15-000365.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.